39 ISSN 1479-6678 10.2217/FCA.13.46 © 2014 Future Medicine Ltd Future Cardiol. (2014) 10(1), 39–41 1University Institute of Sports Medicine, Prevention & Rehabilitation, Salzburg, Austria 2Research Institute of Molecular Sports Medicine & Rehabilitation, Paracelsus Medical University Salzburg, Salzburg, Austria 3Institute of Sports Medicine of the State of Salzburg, Sports Medicine of the Olympic Center Salzburg-Rif, Lindhofstr. 20, 5020 Salzburg, Austria 4The School of Physical Therapy & Rehabilitation Science, The University of Montana, Missoula, MT, USA *Author for correspondence: Tel.: +43 662 4482 4270; Fax: +43 662 4482 4274; j.niebauer@salk.at EuroPRevent, the annual meeting of the European Association of Cardiovascular Prevention and Rehabilitation (EACPR), was held in Rome, Italy in April 2013. While a broad range of sessions covered many topics related to exercise, from biomarkers to public health initiatives, several relevant themes emerged including the primary and secondary prevention of cardiovascular disease (CVD), and the continued evolving use of cardiopulmonary exercise testing to accurately assess the performance of patients with chronic heart failure and those receiving novel therapies, such as ventricular-assist devices. Stemming the cardiovascular event rate in those with and without CVD, and more effectively managing patients with chronic heart failure, is vital to reduce the social and economic burden associated with the rising prevalence of these patient populations. EuroPRevent, the annual meeting of the EACPR, was held in Rome, Italy between 18 and 20 April 2013, with nearly 1600 clinicians and scientists in attendance. This years overall theme was the ‘Universal Approach to Cardiovascular Preventive Cardiology’, which was a very well-chosen topic since the UN target to achieve a reduction in cardiovascular mortality of 25% by 2025 is ambitious but realistic, provided all partners in the medical profession work together. The notion that only a team effort will lead to success was substantiated by the conduction of the first global forum on CVD prevention in clinical practice, but also underscored by an unprecedented number of high-quality sessions that were co-organized with partner societies, as well as Working Groups on Atherosclerosis & Vascular Biology, Hypertension and the Heart, Peripheral Circulation and Thrombosis. The main program of the EACPR meeting consisted of sessions on prevention and rehabilitation, epidemiology, preventive and rehabilitative implementation, sports cardiology, translational science, clinical cases and exercise. A large number of poster presentations provided studies in Insights from major themes at EuroPRevent 2013, Rome, Italy